cancer

Quercetin – an Antioxidant with Neuroprotective and Antiviral Properties

Overview of the Therapeutic Effects of Quercetin

Anti-Aging Drugs

Fourteen ways to extend your life

Interferon-α Inhibits Melanoma Metastasis

IFN-alpha reduces the ability of cancer stem cells to form tumors

Lacidophilin Improves The Efficacy of Interferon α-2b in Treating Human Papillomavirus

Safe prevention of cervical cancer in HPV patients

Interferon Influences the Effectiveness of Radiotherapy

Radiotherapy triggers an antitumor response when it does not target healthy tissue

Lycopene – An Antioxidant for Vascular and Brain Health

Consumption rate and content in products

Interferon-Alpha-2b Is Effective and Safe to Treat Ocular Surface Squamous Neoplasia

The tumor resolved entirely in 83% of cases.

Interferon And Lactation: Clinical Experience with Interferon-Alpha in Breastfeeding

Does interferon-alpha pass into breast milk?

Physical Activity Suppresses Cancer

During exercise, muscles release molecules that slow down the progression of cancer

Type I Interferons Prevent UV-Induced Skin Cancer

Type I interferons stimulate repair of DNA damage and counter suppression of skin immune

Microbiota to Defeat Cancer: Intestinal Bacteria Regulate The Anti-Cancer Response in The Tumor Microenvironment

Microbiota triggers the production of interferon by monocytes, activating anti-tumor immunity

Type I Interferon Accelerates Liver Regeneration After Injury

The role of interferon in the recovery of hepatocytes and the development of hepatocellular carcinoma

Tumor secretes vesicles that suppress the protective response of interferon

To stop the absorption of tumor vesicles means to block the development of metastases

Type I interferons control obesity and cancer

Dual role of endogenous interferon in the control of tumor growth and obesity

Treatment of follicular lymphoma with tumor injections of dendritic cells treated with interferon-α2b

Clinical trial, Phase 1

Immunotherapy complication: cytokine release syndrome

Blocking the increasing production of catecholamines reduces inflammatory damage and mortality